Nektar Therapeutics (NKTR) Q3 2023 Earnings

7NovConfirmed
Q4 2022
Q1 2023
Q2 2023
Q3 2023
-0.45
-0.36
-0.28
-0.19

Details

Expected EPS
-0.2
Actual EPS
-0.19
Surprise EPS
0.01
Surprise Percent
+5%

Description

Nektar Therapeutics (NKTR) has reported earnings of -0.19 per share for Q3 2023.

0 Comments

Share your thoughts